BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 6606107)

  • 1. Preparation of membrane fraction from herpes simplex virus-infected cells which induce cytotoxic T lymphocytes.
    Hitsumoto Y; Sonoda S; Okuyama M; Miki Y; Utsumi S
    Microbiol Immunol; 1983; 27(9):757-65. PubMed ID: 6606107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular interactions in the cytotoxic T lymphocyte response to herpes simplex virus antigens: differential antigen activation requirements for the helper T lymphocyte and cytotoxic T lymphocyte precursors.
    Schmid DS; Rouse BT
    J Immunol; 1983 Jul; 131(1):479-84. PubMed ID: 6223080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell-mediated immunity to herpes simplex virus: induction of cytotoxic T lymphocyte responses by viral antigens incorporated into liposomes.
    Lawman MJ; Naylor PT; Huang L; Courtney RJ; Rouse BT
    J Immunol; 1981 Jan; 126(1):304-8. PubMed ID: 6969745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. II. Bifunctional clones with cytotoxic and virus-induced proliferative activities exhibit herpes simplex virus type 1 and 2 specific or type common reactivities.
    Yasukawa M; Zarling JM
    J Immunol; 1984 Nov; 133(5):2736-42. PubMed ID: 6207243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory effect of herpes simplex virus infection to target cells on recognition of minor histocompatibility antigens by cytotoxic T lymphocytes.
    Kuzushima K; Isobe K; Morishima T; Takatsuki A; Nakashima I
    J Immunol; 1990 Jun; 144(12):4536-40. PubMed ID: 2161874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recognition of herpes simplex virus antigens on the surface of mouse cells of the H-2b haplotype by virus-specific cytotoxic T lymphocytes.
    Jennings SR; Rice PL; Pan S; Knowles BB; Tevethia SS
    J Immunol; 1984 Jan; 132(1):475-81. PubMed ID: 6197457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD4-positive T lymphocytes are required for the generation of the primary but not the secondary CD8-positive cytolytic T lymphocyte response to herpes simplex virus in C57BL/6 mice.
    Jennings SR; Bonneau RH; Smith PM; Wolcott RM; Chervenak R
    Cell Immunol; 1991 Mar; 133(1):234-52. PubMed ID: 1671342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Herpes simplex virus type 1 renders infected cells resistant to cytotoxic T-lymphocyte-induced apoptosis.
    Jerome KR; Tait JF; Koelle DM; Corey L
    J Virol; 1998 Jan; 72(1):436-41. PubMed ID: 9420243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency of herpes simplex virus-specific cytotoxic T lymphocyte precursors in lymph node cells of infected mice.
    Rouse BT; Wagner H
    Immunology; 1984 Jan; 51(1):57-64. PubMed ID: 6317545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. I. Lysis restricted by HLA class II MB and DR antigens.
    Yasukawa M; Zarling JM
    J Immunol; 1984 Jul; 133(1):422-7. PubMed ID: 6609990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Herpes simplex virus-specific human cytotoxic T-cell colonies expressing either gamma delta or alpha beta T-cell receptor: role of accessory molecules on HLA-unrestricted killing of virus-infected targets.
    Maccario R; Comoli P; Percivalle E; Montagna D; Locatelli F; Gerna G
    Immunology; 1995 May; 85(1):49-56. PubMed ID: 7635521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of T cells in anti-herpes simplex virus immunity. I. Induction of antigen-specific cytotoxic T lymphocytes.
    Pfizenmaier K; Jung H; Starzinski-Powitz A; Röllinghoff M; Wagner H
    J Immunol; 1977 Sep; 119(3):939-44. PubMed ID: 70478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protection of mice from fatal herpes simplex virus type 1 infection by adoptive transfer of cloned virus-specific and H-2-restricted cytotoxic T lymphocytes.
    Sethi KK; Omata Y; Schneweis KE
    J Gen Virol; 1983 Feb; 64 (Pt 2)():443-7. PubMed ID: 6601180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infection of BALB/c mice with a herpes simplex virus type 1 recombinant virus expressing IFN-gamma driven by the LAT promoter.
    Ghiasi H; Osorio Y; Hedvat Y; Perng GC; Nesburn AB; Wechsler SL
    Virology; 2002 Oct; 302(1):144-54. PubMed ID: 12429523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. III. Analysis of viral glycoproteins recognized by CTL clones by using recombinant herpes simplex viruses.
    Yasukawa M; Zarling JM
    J Immunol; 1985 Apr; 134(4):2679-82. PubMed ID: 2579149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytotoxic T lymphocytes. Their relevance in herpesvirus infections.
    Martin S; Cantin E; Rouse BT
    Ann N Y Acad Sci; 1988; 532():257-72. PubMed ID: 2845846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotypic identification of antigen-dependent and antigen-independent CD8 CTL precursors in the draining lymph node during acute cutaneous herpes simplex virus type 1 infection.
    McNally JM; Dempsey D; Wolcott RM; Chervenak R; Jennings SR
    J Immunol; 1999 Jul; 163(2):675-81. PubMed ID: 10395657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA-unrestricted killing of HSV-1-infected mononuclear cells. Involvement of either gamma/delta+ or alpha/beta+ human cytotoxic T lymphocytes.
    Maccario R; Revello MG; Comoli P; Montagna D; Locatelli F; Gerna G
    J Immunol; 1993 Feb; 150(4):1437-45. PubMed ID: 8381835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunological studies of herpetic keratitis: induction of cytotoxic T lymphocytes in mouse splenocytes.
    Hirakawa Y; Kondo H; Hiyama N; Sakata H
    Jpn J Ophthalmol; 1985; 29(3):241-9. PubMed ID: 3878428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apparent requirement for CD4+ T cells in primary anti-herpes simplex virus cytotoxic T-lymphocyte induction can be overcome by optimal antigen presentation.
    Mercadal CM; Martin S; Rouse BT
    Viral Immunol; 1991; 4(3):177-86. PubMed ID: 1687350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.